Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CYCLOSPORINE Cause Cystitis haemorrhagic? 591 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 591 reports of Cystitis haemorrhagic have been filed in association with CYCLOSPORINE (Verkazia). This represents 0.9% of all adverse event reports for CYCLOSPORINE.

591
Reports of Cystitis haemorrhagic with CYCLOSPORINE
0.9%
of all CYCLOSPORINE reports
166
Deaths
190
Hospitalizations

How Dangerous Is Cystitis haemorrhagic From CYCLOSPORINE?

Of the 591 reports, 166 (28.1%) resulted in death, 190 (32.1%) required hospitalization, and 37 (6.3%) were considered life-threatening.

Is Cystitis haemorrhagic Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CYCLOSPORINE. However, 591 reports have been filed with the FAERS database.

What Other Side Effects Does CYCLOSPORINE Cause?

Drug ineffective (11,172) Off label use (6,860) Eye irritation (5,806) Product use in unapproved indication (5,019) Condition aggravated (2,310) Eye pain (2,197) Drug intolerance (2,176) Pneumonia (2,022) Pyrexia (2,020) Treatment failure (1,961)

What Other Drugs Cause Cystitis haemorrhagic?

CYCLOPHOSPHAMIDE (1,036) MYCOPHENOLATE MOFETIL (476) METHOTREXATE (413) FLUDARABINE (386) BUSULFAN (336) TACROLIMUS (336) MESNA (294) LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN (289) RITUXIMAB (261) DOXORUBICIN (212)

Which CYCLOSPORINE Alternatives Have Lower Cystitis haemorrhagic Risk?

CYCLOSPORINE vs CYCLOSPORINE A CYCLOSPORINE vs CYMBALTA CYCLOSPORINE vs CYNODON DACTYLON POLLEN CYCLOSPORINE vs CYPROHEPTADINE CYCLOSPORINE vs CYPROTERONE

Related Pages

CYCLOSPORINE Full Profile All Cystitis haemorrhagic Reports All Drugs Causing Cystitis haemorrhagic CYCLOSPORINE Demographics